Abstract:Background Acute renal failure (ARF) remains a frequent clinical complication, Ischemia is the major cause of acute kidney injury (AKI), associated with high mortality and morbidity. Mesenchymal stem cells (MSCs) have multilineage differentiation potential and can be a potent therapeutic option for the cure of AKI. The aim of this study was, therefore, to evaluate the therapeutic effectiveness of bone marrow–derived mesenchymal stem cells in a rat model of ischemia/reperfusion (I/R) ARF. Materials and Methods MSCs were cultured and rats were used as a common I/R model to induce ARF by clamping both renal pedicles for 45 minutes then stem cells were transplanted. Ki-67 was used as marker for regeneration of renal tubulointerstitial injury. Results This study reports that Rat MSCs decreased cell apoptosis and increased proliferation and reduced fibrosis in common I/R model in rats. Conclusion MSCs may be useful in regeneration of renal tubulointerstitial injury. INTRODUCTION The kidney is comprised of heterogeneous cell populations that function together to perform a number of tightly controlled and complex processes. Renal ischemia\ reperfusion (I\R) injury is a common cause of acute renal failure and contributed to consider able morbidity associated with surgery and anesthesia (Chander et al., 2006). One cause of acute kidney injury (AKI) is ischemia which can occur for a number of reasons, for example with the use of the vasoconstrictive drugs or radiocontrast agents; hypotension linked to loss of blood after surgery (Asif and Bruce, 2011). Stem cells play fundamental roles in the self-renewal of adult tissues throughout life. Bone marrow–derived hematopoietic stem cells have been discovered to transdifferentiate into cells of different germ layers (Krause et al., 2001). Physiologically, mesenchymal stem cells give rise to osteocytes, chondrocytes, and adipocytes, but were recently found to differentiate into endothelial, myocardial (Nagaya et al., 2004), liver (Shu et al., 2004), renal (Morigi et al., 2004), and pulmonary epithelial cells (Ortiz et al., 2003). Based on this background, the objective of the present study was to test the therapeutic potential of mesenchymal stem cells, administered to rats following induction of ARF by ischemia/reperfusion (I/R) and showed the regeneration of renal tubulointerstitial injury that marked by the pathological change and uses of marker Ki-67. Materials and Methods: Animals were approved by the animal house, faculty of science, Zagazig University, Egypt. I/R (ARF) were induced in anesthetized (ketamine/valpam) adult male Sprague Dawley rats, weighing 200 to 250 g by clamping both renal pedicles for 45 minutes. Then animals were injected with 4 ml warmed normal saline gave intraperitoneally before abdominal closure. (Claudia et al., 2005) Cell culture and transplantation Rat mesenchymal stem cells were generated from the bone marrow of adult Sprague-Dawley rats by standard procedures (Javazon et al., 2001, Lange et al., 2003). Mesenchymal stem cells used in this study were cultured for more than 3 passages, which practically excludes hematopoietic cell contamination. After 3 days of isolation non-adherent cells were removed by two to three washes with PBS and adherent cells further cultured in complete medium. The medium was changed every 3 days until the monolayer of adherent cells reach 7080% confluence. Trypsinization was made for cell splitting by Trypsin/EDTA solution (0. 25%, lonza, USA) for passage 1 .Number of cells were evaluated by Homocytometer and cellular viability by the Trypan Blue exclusion test. Each 250-300 × 103 cells were inoculated in 75 Cm2 culture flask that were incubated at 37oC and 5% CO2. Cell cultivation was maintained up to the 3rd passage. After reflow, 2 × 106 mesenchymal stem cells in 0.5 mL of complete medium were infused into the renal vein. (Uta et al., 2007). Biochemical study: Renal function was monitored by measurement of serum creatinine according to the method of (Young., 2001) and blood urea nitrogen (BUN) according to the method of (Henry et al., 1974) Histopathology study: a) Histology The kidneys were fixed in a 10% neutral-buffered formalin solution, embedded in paraffin and 5μ thick sections were stained with Hematoxylin and Eosin for injury scoring according to a previously published guideline. (Solezk et al., 1979) b) Imunohistochemstry Other sections were stained with Ki-67 imunohistochemstry

Role of Mesenchymal Stem Cell in Identification of Hemotoxic Effect of sFas in cases of Nephrotoxicity

The preliminarily investigation of therapeutic effects of mesenchymai stem cells on rat fulminant hepatic failure

Can mobilization of bone marrow stem cells be an alternative regenerative therapy to stem cell injection in a rat model of chronic kidney disease?

Impact of Mesenchymal Stromal Cells and Their Extracellular Vesicles in a Rat Model of Kidney Rejection

GENETIC AND HISTOLOGICAL STUDIES ON EFFECT OF MESENCHYMAL STEM CELL THERAPY ON EXPERIMENTAL RENAL INJURY INDUCED BY CISPLATIN IN MALE ALBINO RATS

Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants

Efficacy of stem cells versus microvesicles in ameliorating chronic renal injury in rats (histological and biochemical study)

The hepato-protective effect of H2S-modified and non-modified mesenchymal stem cell exosomes on liver ischemia-reperfusion injury in mice: The role of MALAT1

[Magnetic Resonance Imaging of Mesenchymal Stem Cells Transplanted Intravascularly in Treatment of Acute Renal Failure:In Vivo Experiment with Rats].

Comparative histological study of therapeutic effect of mesenchymal stem cells versus mesenchymal stem cells co-cultured with liver tissue on carbon tetrachloride-induced hepatotoxicity in adult male albino rats

The Effect of Mesenchymal Stromal Cells on Doxorubicin-Induced Nephropathy in Rats

AB0045 MESENCHYMAL STEM CELLS INHIBIT THE ACTIVATED COMPLEMENT C5 BY CLUSTERIN IN LUPUS NEPHRITIS

Biochemical Evaluation to Mesenchymal Stem Cells Therapy of Renal Tubulointerstitial Injury

Effects Of Allogeneic Mesenchymal Stem Cell Transplantation In The Treatment Of Liver Cirrhosis Caused By Autoimmune Diseases

Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury

Mesenchymal stem cells infusion prevents acute cellular rejection in rat kidney transplantation

Bone marrow-derived mesenchymal stem cells reduce CCl4-induced kidney injury and fibrosis in male Wistar rats

Mesenchymal stem cells transplantation attenuates hyperuricemic nephropathy in rats

Bone marrow-derived mesenchymal stem cells ameliorate liver injury in a rat model of sepsis by activating Nrf2 signaling

Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model

Evaluation of the healing and protective properties of adipose-derived mesenchymal stem cells from cisplatin-induced liver and kidney damage